drugset / Trial / NCT03937505
A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy
Non-randomizedSequentialOpen-labelPrevention
Summary
This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation. Stage A of the study will determine the safe optimal dose and Stage B will determine expanded safety and efficacy for intraoperative ureter structure delineation for the identified optimal dose in study participants.
Timeline
- Start
- 2019-05-28
- Primary completion
- 2021-07-08
- Completion
- 2021-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IS-001 | Diagnostic / imaging agent | 20 mg | Intravenous |